Gene: GPR35
Official Full Name: G protein-coupled receptor 35provided by HGNC
Gene Summary: Enables C-X-C chemokine receptor activity. Involved in chemokine-mediated signaling pathway; negative regulation of voltage-gated calcium channel activity; and positive regulation of cytosolic calcium ion concentration. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37539 | GPR35 Knockout cell line (HCT 116) | Human | GPR35 | 1:2~1:4 | Negative | Online Inquiry |
KO37540 | GPR35 Knockout cell line (HEK293) | Human | GPR35 | 1:3~1:6 | Negative | Online Inquiry |
KO37541 | GPR35 Knockout cell line (A549) | Human | GPR35 | 1:3~1:4 | Negative | Online Inquiry |
GPR35 Gene Knockout Cell Lines are specifically engineered cellular models that possess a deletion of the GPR35 gene, which encodes a G protein-coupled receptor involved in a range of physiological processes including immune response, metabolism, and inflammation. These knockout cell lines provide a unique platform for investigating the biological functions of GPR35 and its role in various pathological conditions.
The primary function of GPR35 is to mediate signaling pathways that can influence cellular responses to various stimuli, particularly involving ligands such as kynurenine and other metabolites. By employing these knockout cell lines, researchers can elucidate the specific pathways and networks activated by GPR35, enabling the identification of new therapeutic targets and biomarkers in conditions like cancer, obesity, and autoimmune diseases. The absence of the GPR35 gene allows for comparative studies between wild-type and knockout cells, revealing the receptor's role in cell proliferation, migration, and signaling.
In the scientific community, GPR35 knockout cell lines are invaluable for drug discovery and development. The models can be utilized in high-throughput screening assays to identify novel compounds that modulate GPR35 activity, providing insights into its potential therapeutic applications. These cell lines are also essential for in-depth studies aimed at understanding the receptor's contribution to disease mechanisms, opening new avenues for research in translational medicine.
What sets GPR35 Gene Knockout Cell Lines apart from other cell line models is their specificity and reliability in mimicking the loss of GPR35 function. They offer researchers the capacity to conduct focused studies without the confounding variables often present in heterogeneous systems. This specificity enhances the reproducibility of results, making them a preferred choice for both academic and commercial laboratories.
In summary, GPR35 Gene Knockout Cell Lines represent a powerful tool for scientists and clinicians aimed at exploring the intricate roles of GPR35 in health and disease. Our company, with its deep expertise in genetic engineering and cell line development, is committed to providing high-quality biological products that facilitate groundbreaking research and contribute to advances in clinical therapies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.